John Durfee
Overview
Explore the profile of John Durfee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schorge J, Bregar A, Durfee J, Berkowitz R
Gynecol Oncol
. 2018 Mar;
149(3):447-454.
PMID: 29525276
Joe V. Meigs was a visionary clinician and an early adopter of radical techniques in the surgical treatment of ovarian cancer. His 1934 textbook "Tumors of the Female Pelvic Organs",...
2.
Randall T, Goodman A, Schmeler K, Durfee J, Pareja R, Munkarah A, et al.
Gynecol Oncol
. 2016 May;
142(1):6-8.
PMID: 27210817
Women in low- and middle-income countries (LMICs) face a drastically increased burden of cervical cancer and the same burden of other gynecologic cancers as do women in high-income countries, yet...
3.
Weng D, Song B, Durfee J, Sugiyama V, Wu Z, Koido S, et al.
Int J Cancer
. 2010 Dec;
129(8):1990-2001.
PMID: 21154809
The majority of patients with stage III/IV ovarian carcinoma that respond initially to standard therapies ultimately undergo relapse due to the survival of small populations of cells with tumor-initiating potential....
4.
Gong J, Zhang Y, Durfee J, Weng D, Liu C, Koido S, et al.
J Immunol
. 2009 Dec;
184(1):488-96.
PMID: 19949080
In previous studies, we have shown that heat shock protein 70-peptide complexes (HSP70.PCs) derived from the fusion of dendritic cells (DCs) to tumor cells (HSP70.PC-F) possess superior properties compared with...
5.
Carter J, Durfee J
Gynecol Oncol
. 2007 Oct;
107(3):586-9.
PMID: 17949798
Background: Bowel perforation is a rare complication of chemotherapeutic treatment of cancer, and may result from tumor necrosis within involved bowel or as a function of the mechanism of the...
6.
Koido S, Ohana M, Liu C, Nikrui N, Durfee J, Lerner A, et al.
Clin Immunol
. 2004 Oct;
113(3):261-9.
PMID: 15507391
Fusion of human dendritic cells (DC) with tumor cells is an effective approach for delivering tumor antigens to DC, and DC/tumor fusion cells are potent stimulators of autologous T cells....